Loading...
XSHE
002950
Market cap1.02bUSD
Dec 05, Last price  
11.55CNY
1D
0.96%
1Q
15.04%
IPO
-0.86%
Name

Allmed Medical Products Co Ltd

Chart & Performance

D1W1MN
XSHE:002950 chart
P/E
19.71
P/S
2.18
EPS
0.59
Div Yield, %
0.24%
Shrs. gr., 5y
-0.27%
Rev. gr., 5y
7.17%
Revenues
3.33b
+20.66%
1,509,026,3351,585,173,8721,558,085,3161,711,115,9872,027,512,0392,352,461,8043,834,498,0222,925,554,8874,210,502,6512,756,665,3243,326,292,089
Net income
369m
+233.95%
198,425,429156,979,958248,134,445233,733,422227,781,022325,812,4601,157,526,566431,214,849406,791,688110,399,864368,679,147
CFO
712m
+66.93%
293,445,400217,679,150472,739,463197,249,6853,008,664273,132,3851,436,740,713374,852,2021,149,727,552426,301,025711,644,736
Dividend
Jun 19, 20240.027051 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Allmed Medical Products Co., Ltd engages in the manufacture and sale of wound care and nursing material products in China. The company's general wound care products include elastic and adhesive bandage, oil emulsion, xeroform gauze, woven gauze swabs, fluffy bandages/sponges, abdominal pads, gauze/non-woven drain sponges, post-op sponges, eye pads, cotton filled exodontia sponges, non-stick pads, and petrolatum gauze dressing. It also provides OR/surgery products, including X-ray non-woven swabs, OR towels, laparotomy and neuro sponges, X-ray gauze swabs, and X-ray detectable gauze balls and nonwoven balls; various kits; and patient care products comprising disposable nursing pads and disposable drapes. The company also exports its products. Allmed Medical Products Co., Ltd was founded in 1992 and is based in Shenzhen, the People's Republic of China.
IPO date
Mar 11, 2019
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT